AdvanDx Welcome Graphic
AdvanDx Publications 2.8.2010 | Pseudomonal vs. Non-Pseudomonal Therapy
2.3.2010 | US Package Insert for E. coli/P. aeruginosa PNA FISH
1.19.2010 | PNA FISH results confirmed that the representative isolates from all five episodes were S. aureus
Learn More About AdvanDx AdvanDx develops and markets molecular-based, in vitro diagnostic tests that aid in the diagnosis and prevention of infectious diseases. The rapid test results are available within hours instead of days and allow healthcare providers to make more informed therapy decisions early and improve both the quality of patient care and overall hospital operations.
More About Us PNA Fish Evigene
AdvanDx News 1.22.2010 | Updates on efforts to improve antibiotic prescribing and patient outcomes via rapid diagnosis of serious infections and sepsis.

12.22.2009 | Faster Results to Help Clinicians Improve Pseudomonal vs. Non-Pseudomonal Antibiotic Selection for Patients with Critical Infections

12.10.2009 | Faster Results to Help Clinicians Improve Antibiotic Selection and Outcomes for Patients with True Staphylococcal Infections while Avoiding...